GSK3B and glioblastoma: To investigate whether quercetin inhibits the EMT-like mesenchymal transition of GBM via GSK3β/β-catenin/ZEB1signialing pathway, we used western blotting assays to assess the change of these signaling pathway proteins upon quercetin treatment.